ZLAB (Zai Lab Limited) Stock Market Reviews

crown

search

Read and share opinions on ZLAB (Zai Lab Limited) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock market.

ZLAB

Zai Lab Limited

clarify Biotechnology

bookmark Healthcare

public China

Sell Neutral Buy

Latest News

What Does The Future Hold For Zai Lab Limited (NASDAQ:ZLAB)? These Analysts Have Been Cutting Their Estimates
Nov 7, 2025
Zai Lab Ltd (ZLAB) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges
Nov 6, 2025
Zai Lab Announces Third Quarter 2025 Financial Results and Recent Corporate Updates
Nov 6, 2025
Zai Lab Announces Participation in Investor Conferences in November and December 2025
Oct 31, 2025
Zai Lab (NasdaqGM:ZLAB): Exploring Valuation After a 23% One-Month Share Price Decline
Oct 30, 2025
Zai Lab Says Potential Lung Cancer Treatment Shows High Response Rate in Updated Phase 1 Data
Oct 24, 2025
Zai Lab Announces Updated Phase 1 Data for Zocilurtatug Pelitecan (formerly ZL-1310), Demonstrating Potential as a First-in-Class/Best-in-Class DLL3-Targeted ADC for Small Cell Lung Cancer, and Initiation of Global Phase 3 Registrational Study
Oct 24, 2025
A Look at Zai Lab (NasdaqGM:ZLAB) Valuation Following Key Clinical Progress and New Data Announcement
Oct 15, 2025
Zai Lab to Announce Third Quarter 2025 Financial Results and Recent Corporate Updates on November 6, 2025
Oct 15, 2025
Zai Lab Announces Oral Presentation of Updated Data from Global Phase 1 Trial of Zocilurtatug Pelitecan (ZL-1310), a Potential First-in-Class DLL3-Targeted ADC, at 2025 AACR-NCI-EORTC Conference
Oct 13, 2025
Zai Lab Limited (ZLAB): A Bull Case Theory
Sep 16, 2025
Zai Lab Announces Approval of TIVDAK® for Patients with Recurrent or Metastatic Cervical Cancer in Hong Kong
Sep 2, 2025
Zai Lab Announces Participation in Investor Conferences in September 2025
Aug 28, 2025

Reviews